1. Understand the evolving predictive role of the 21 gene assay in hormone positive breast cancer.
2. Appreciate multiple available adjuvant strategies for optimizing survival outcomes in hormone positive breast cancer.
3. Review pathological guidelines and considerations for diagnosis and management of HER2neu indeterminate breast cancers.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation